Alder Biopharma (ALDR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 0 | 936 | 0 | 683 | 0 |
| Cost of Goods | N/A | 936 | N/A | 683 | N/A |
| Operating Expenses | 85,601 | 56,022 | 60,424 | 75,507 | 100,670 |
| Operating Income | -85,601 | -55,086 | -60,424 | -74,824 | -100,670 |
| Interest Expense | 2,851 | 0 | 0 | 0 | 0 |
| Other Income | 1,421 | 729 | 859 | 195 | 342 |
| Pre-tax Income | -87,031 | -54,357 | -59,565 | -74,629 | -100,328 |
| Net Income Continuous | -87,031 | -54,357 | -59,565 | -74,629 | -100,328 |
| Net Income | $-87,031 | $-54,357 | $-59,565 | $-74,629 | $-100,328 |
| EPS Basic Total Ops | -1.73 | -0.56 | -0.92 | -1.48 | -1.99 |
| EPS Basic Continuous Ops | -1.28 | -0.56 | -0.92 | -1.48 | -1.99 |
| EPS Diluted Total Ops | -1.73 | -0.56 | -0.92 | -1.48 | -1.99 |
| EPS Diluted Continuous Ops | -1.28 | -0.56 | -0.92 | -1.48 | -1.99 |
| EPS Diluted Before Non-Recurring Items | -1.73 | -0.80 | N/A | N/A | N/A |
| EBITDA(a) | $-84,800 | $-54,323 | $-59,672 | $-74,085 | $-99,923 |